Atherosclerosis is an inflammatory disease due to a diet high in saturated fat , hypercholesterolemia, obesity, hypoglycemia, etc. mainly mediated by the infiltration of macrophage and T cells into the vascular wall. Once the endothelial is damaged monoc ytes penetrate the tissue and are transformed in scavenger cells. Upon stimulation ofThl cells, a group ofcytokines is released and contributes to the inflammatory response of atherosclerotic tissue. When macrophages proliferate they amplify inflammatory response through the secretion of growth factors and cytokines such as TNF and IL-l. In addition, chemokines such as RANTES and other C-C chemokines are generated, and matrix metalloprotinease 9 (MMP-9) are produced by activated monocytes. However, the immune system in atherosclerosis still remains unclear. Here, in this study we revisited the inter-relationship between atherosclerosis and inflammation.
Atherosclerosis is the condition in which the inner layers of the artery wall, known as intima , become thick and irregul ar due to the deposits of fats (mainly in the form of cholesterol and another fat called phospholipid) and other substances. When these deposits occur in the arteries that suppl y blood to the heart the condit ion is called coronary atherosclerosis. As the build -up grows, the artery narrows and the flow of blood to the heart muscle is reduced. Like any other muscle, the heart needs blood to provide it with oxygen . When that blood flow is reduced or compl etely blocked, some of the cells in the heart muscle can die. Scientists divide the telltale sign of atherosc lerosis into two major types: the earlie st depos its called fatty streak s, and advance deposits called plaques. Fatty streaks which contain about 25% fat can be seen in the arteries eve n in children. Durin g the development of fatty streaks, the cells that line the arteries are stimulated to take in more cholesterol than they can handle.
Although this process is not completely understood, it may begin when the endothelium, the thin layer of cells lining the inside of the artery, is damaged. Once the endothelial is damaged monocytes, which play a role in the body's healing process, may penetrate the endothelium. Once inside, the monocytes are transformed into scavenger cells. When the cholesterol level in the blood is high, these scavengers begin collecting cholesterol, forming a fatty streak. Some of these fatty streaks can grow into plaques as other cells begin accumulating and growing around the site of injury. Several types of cells appear to play important roles in this process including smooth muscle cells which are normally found in the middle layers of the blood vessel wall; platelets, which are elements of the blood clotting process, and endothelial cells themselves which release chemicals called growth factors that hasten the formation of fatty plaques. Plaque is a hallmark of coronary atherosclerosis -it forms as more cholesterol is deposited at the sites of the fatty streaks. As plaque grows, it narrows the arteries and restricts the blood flow to the heart, causing coronary heart disease.
In chronic rejection with graft atherosclerosis, injury to the vessel wall leads to intimal smooth muscle cell proliferation and luminal occlusion. This lesion may be caused by a chronic delay typehypersensitivity reaction to alloantigens in the vessel wall. The major cause of the chronic rejection of vascularized organ grafts may be arterial occlusion as a result of the proliferation of intimal smooth muscle cells. This process is called graft atherosclerosis. The smooth muscle cell proliferation in the vascular intima may represent a specialized form of chronic delayed type hypersensitivity reaction of the organ parenchyma in which lymphocytes activated by alloantigens in the graft vessel wall induce macrophages to secrete smooth muscle cell growth factors.
Atherosclerosis is an inflammatory disease characterized by vascular wall infiltration by macrophages and T cells associated with lipid infiltration (1-5). Implication of the immune system in atherosclerosis is still incompletely understood, but recent works have highlighted the role of the innate immune system in generating a response in the presence of tissue aggression, which would subsequently lead to the activation of inflammatory pathways (6) (7) (8) . Therefore, the metabolic perturbations that mediate important and complex interactions with the immune system and the vascular wall in relation with atherosclerosis are reviewed with an emphasis on the mechanisms that mediate immune activation. The local production of these mediators enhances the influx of new immune cells and promotes the progression of the atherosclerotic lesion.
The preferential differentiation of naive CD4 T cells into effector Thl cells upon antigenic stimulation of T cells contributes to atherosclerosis. Upon stimulation, effector T cells produce a wide range of pro-atherosclerotic cytokines. The stimulation of effector T cells results from the interaction of the T-cell receptor with major histocompatibility complex class II in combination with co-stimulatory activation via receptor-ligand interactions.
The hypothesis that the classical Th I/2 balance determines the outcome of atherosclerosis is now challenged by the important role of regulatory T cells (Tregs) in atherosclerosis. Tregs are known to dampen inflammatory responses in several autoimmune-like diseases, and these cells may hold promise for the treatment of atherosclerosis (9-11).
Proinflammatory stimuli, including a diet high in saturated fat, hypercholesterolemia, obesity, hyperglycemia, insulin resistance, hypertension, and smoking, trigger the endothelial expression of adhesion molecules, such as P-selectin and vascular cell adhesion molecule-l (YCAM-I), which mediate the attachment of circulating monocytes and lymphocytes (12) (13) (14) (15) (16) (17) (18) (19) (20) (21) (22) (23) (24) . Interestingly, atherosclerotic lesions often form at bifurcations of arteries, regions characterized by disturbed blood flow, which reduce the activity of endothelial atheroprotective molecules, such as nitric oxide, and favor regional YCAM-l expression (25-29).
Accumulation of cholesteryl esters in the cytoplasm converts macrophages into foam cells, i.e., lipid-laden macrophages characteristic of earIystage atherosclerosis. In parallel, macrophages proliferate and amplify the inflammatory response through the secretion of numerous growth factors and cytokines, including TNF-a and IL-I p. Recent evidence supports selective recruitment of a proinflammatory subset of monocytes to nascent atheroma in mice (30-38). These observations point to a previously unappreciated layer of complexity in the inflammatory aspects of early atherogenesis. Macrophages and T cells infiltrate atherosclerotic lesions and localize, particularly in the shoulder region, where the atheroma grows.
Neovascularization arising from the artery 's vasa vasorum contributes to lesion progression in many ways (39) (40) (41) (42) . It provides another portal for leukocyte entry into established atherosclerotic lesions (43) (44) (45) (46) . In addition, these fragile neovessels can favor focal intraplaque hemorrhage that provides a mechanism for the discontinuous increments seen in plaque growth. Local hemorrhage within the plaque in tum generates thrombin, which activates ECs, monocytes/macrophages, SMCs, and platelets (47) (48) (49) (50) . These cells respond to thrombin by producing a broad array of inflammatory mediators, including CD40L, RANTES (regulated on activation, normal T cell expressed and secreted), and macrophage migration inhibitory factor. These molecules further promote lesion formation and favor the thrombotic complications of atherosclerosis (5 I-54) . Platelets also playa central role in the biology of atherosclerosis by producing inflammatory mediators such as CD40L, myeloid-related protein-8/14, and platelet-derived growth factor, as well as directing leukocyte incorporation into plaques through platelet-mediated leukocyte adhesion. These results reveal the synergism between inflammation and thrombosis in the pathobiology of atherothrombosis (43) .
Although vaccination against IL-12 may be considered a promising new strategy in the treatment of atherosclerosis, anti-IL-12 antibody treatment, which has been proved a safe treatment, may be a more clinically relevant step towards the clinical translation of these studies (55) (56) (57) (58) . In addition, blockade of other pro-inflammatory interleukins, such as IL-20 (59-65), may be an attractive approach to increase the stability of the atherosclerotic lesion .
As outlined, T-cell activation is an important step in atherosclerosis, and it is initiated by antigen recognition in combination with co-stimulatory signals provided by APCs . The best-defined signals are delivered by B7 family molecules on APCs binding to CD28 on T cells, and a deficiency in B7-1 and B7-2 reduces atherosclerosis and IFN-y production by antigen-specific T cells (66) (67) (68) (69) . T-cell co-stimulation directly influences the CD40lCD40L immunoregulatory pathway, which is well known to influence atherosclerosis (70) (71) (72) (73) (74) (75) (76) (77) (78) (79) (80) . CD40L plasma concentrations correlate with the risk of CVD, and it has recently been suggested that not only CD40Ll CD40 co-stimulation affects atherosclerosis, but the interaction of CD40L and Mac-I may form an alternative pathway for CD40L-mediated inflammation (70) . CD40 activation on endothelial cells by CD40L-positive cells activates endothelial tumour necrosis factor receptor-associated factors and identifies these molecules as potential targets for selective therapeutic intervention (75) . The OX401 OX40L pathway is an additional co-stimulatory pathway that affects atherosclerosis.
The innate immune response in atherosclerosis is initiated by the response of arterial endothelial cells to modified lipoproteins, which leads to their activation and the production of chemokines that attract monocytes to the site of injury. There, monocytes take up (modified) lipoproteins and the subsequent foam cell formation leads to an innate immune response that is characterized by the production of chemokines and interleukins (ILs). The local production of these mediators enhances the influx of new immune cells and promotes the progression of the atherosclerotic lesion.
Monocytic cells directly interacting with human ECs increase monocyte matrix metalloproteinase 9 (MMP-9) production several fold, allowing for the subsequent infiltration of leukocytes through the endothelial layer and its associated basement membrane (81) (82) (83) (84) . Within the intima, monocytes mature into macrophages under the influence of macrophage colony-stimulating factor, which is over-expressed in the inflamed intima (85) (86) (87) (88) (89) (90) (91) (92) (93) . Macrophage colony-stimulating factor stimulation also increases macrophage expression of scavenger receptors, members of the pattern-recognition receptor superfamily, which engulf modified lipoproteins through receptor-mediated endocytosis. Accumulation of cholesteryl esters in the cytoplasm converts macrophages into foam cells, i.e., lipidladen macrophages characteristic of early-stage atherosclerosis.
A number of studies during the past year have implicated an important role of Tregs in atherosclerosis (98) (99) (100) (101) (102) (103) (104) (105) (106) . Tregs can counteract effector T cells, and activation ofTregs may form an attractive new immunotherapy for atherosclerosis. The main subsets of Tregs are CD4+CD25+Foxp3+ T cells (natural Tregs), type I Tregs and Th3 cells (adaptive Tregs) that may acquire Foxp3 expression in the periphery, and all these types of Tregs are essential for the maintenance of peripheral tolerance (107) (108) (109) . A final class of immune cells that modulate atherosclerosis is NKT cells, which respond to lipid antigens. It was recently shown that the transfer of spleen-derived NKT cells from V[alpha]14J[alpha]18 T-cell receptor transgenic mice resulted in a 73% increase in lesion area (107) . Interestingly, VanderLaan et al. also demonstrated that an endogenous serum lipid carried by lipoproteins activates the NKT cells, which may provide a possibility to intervene in the recognition or level of this lipid and to modulate atherosclerosis (110) .
Inflammatory processes play a crucial role in the initiation and progression of atherosclerosis and coronary heart disease such as myocardial infarction. Several authors have shown that statins regulate Til1/ T II2 imbalance both in vitro and in vivo. Thus, all these observations could explain the beneficial effect of statins in atherosclerosis because it has been shown that the T112 cytokines have anti-atherogenic properties, and their overexpression protects against atherosclerosis.
Furthermore, statins suppress the secretion of proinflammatory cytokines including IL-I~and IL-6, but not tumor necrosis factor a (TNF-a). These results support human studies suggesting that statins decrease the number of inflammatory cells in atherosclerotic plaque (II I). NO plays a crucial role in mediating this anti-inflammatory action. 
